12 Best Forever Stocks To Buy Now
Investment opportunities are increasingly cropping up as volatility in the equity markets edges higher in response to changes in the investment environment.
Eli Lilly & Co (LLY)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Fisher Asset Management Ken Fisher | 4,888,710 | $4,426,141,743 | +5% | 1.92% |
| 2. | GQG Partners Rajiv Jain | 4,007,699 | $3,628,490,096 | +5% | 5.5% |
| 3. | 1,306,100 | $1,182,516,818 | -25% | 0.23% | |
| 4. | 1,192,200 | $1,079,394,036 | -17% | 0.21% | |
| 5. | Tiger Global Management LLC Chase Coleman And Feroz Dewan | 930,000 | $842,003,400 | +5% | 3.89% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $304.19 | 656 | Director | 62,857 | 2022-08-12 | Filing | |
| $246.78 | 202 | Director | 15,436 | 2022-03-01 | Filing | |
| $182.99 | 546 | Director | 61,195 | 2021-04-30 | Filing | |
| $182.74 | 820 | Director | 60,649 | 2021-04-30 | Filing | |
| $108.84 | 1,000 | Officer | 22,043 | 2019-10-25 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $969.18 | 979 | 96,891,978 | 2024-09-03 | Filing | ||
| $968.31 | 1,600 | 96,892,957 | 2024-09-03 | Filing | ||
| $967.28 | 5,320 | 96,894,557 | 2024-09-03 | Filing | ||
| $966.19 | 16,185 | 96,899,877 | 2024-09-03 | Filing | ||
| $972.24 | 100 | 96,916,062 | 2024-08-27 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 99,768,810 | $58,157,234,725 | 100% | |
| 2. | 71,611,201 | $41,743,601,288 | 0.91% | |
| 3. | 64,366,433 | $37,520,480,985 | 0.95% | |
| 4. | 33,787,327 | $19,695,308,655 | 0.95% | |
| 5. | 32,845,420 | $19,146,252,327 | 1.47% |
News See All
Must-See: Jim Cramer’s 10 Best Stock Picks for Investors Right Now
In a recent episode of Mad Money, Jim Cramer discussed how the slowing economy might lead the Federal Reserve to ease its policies.
Morgan Stanley's Best Stock Picks: 15 Stocks To Own For 2025
The tail end of 2024 is seeing a market shift in the stock market as the Federal Reserve has finally signaled that interest rate cuts are on the horizon.
10 Best Counter Cyclical and Defensive Stocks to Invest In
Volatility in the U.S. equity market is edging higher heading into year-end as investors react to a string of economic and geopolitical developments. Uncertainty over the outcome of the upcoming U.S.
10 Unstoppable Dividend Stocks to Buy
It's undeniable that dividends have played a key role in the market's returns over the past year. While they hit a rough patch for a bit, these stocks still have plenty of room to grow.
7 Best Big Company Stocks to Buy Now
Mega-cap stocks—major technology companies to be precise—continued to drive a disproportionate share of the total US stock market returns.
10 Large Cap Stocks Jim Cramer Can't Stop Talking About
In a recent episode of Mad Money, Jim Cramer highlights a critical gap in the American education system, which often overlooks financial literacy despite its importance.
Starter Stock Portfolio: 10 Safe Stocks To Invest In Now
A probable rate cut has provided hope for the economy. Despite that, the impact on financial markets and stocks remains uncertain.
10 Best ESG Stocks To Buy Now
Defining ESG can sometimes be straightforward: it’s a finance and investing approach centered on managing risks related to environmental factors, social issues, and corporate governance.
10 Best Cancer Stocks To Buy Now
In 2022, the global oncology market was valued at approximately $203.42 billion and is expected to reach over $470.61 billion by 2032, growing at a compound annual growth rate (CAGR) of 8.8% from 2023...